Does Vascepa's Patient Assistance Program Have an Annual Limit?
Vascepa (icosapent ethyl), made by Amarin, offers the VASCEPA360 patient support program, which includes copay assistance for eligible commercially insured patients. This covers out-of-pocket costs like copays and deductibles up to $18,000 per calendar year per patient. Once that cap is reached, the program stops covering further costs for the year.[1]
Who Qualifies and What Are the Restrictions?
Eligibility requires commercial insurance (not government plans like Medicare or Medicaid), a valid prescription for Vascepa, and U.S. residency. Annual household income must be under $100,000 for maximum benefits, though higher earners may get partial help. The program excludes free trial offers and doesn't apply to cash-paying patients.[1][2]
What Happens After Hitting the $18,000 Cap?
Patients pay full out-of-pocket costs beyond the cap until the next calendar year resets. No carryover or extensions exist. Some switch to manufacturer discount cards or patient assistance foundations like PAN Foundation for additional help, but those have separate limits.[2]
How Does This Compare to Other Drug Assistance Programs?
Vascepa's $18,000 annual cap is higher than many (e.g., some copay cards cap at $5,000–$10,000), reflecting its high list price (around $4,500–$9,000 for a 30-day supply). Competitors like Lovaza (prescription fish oil) have lower caps around $8,000. Programs for newer CVD drugs like Leqvio often match or exceed this.[3]
When Does Enrollment End or Renew?
Assistance renews January 1 each year. Cards expire after 12 months or upon cap exhaustion. Patients reapply via VASCEPA360.com or by calling 1-833-VASCEPA.[1]
[1] VASCEPA360 Official Program Details
[2] NeedyMeds Vascepa Assistance Overview
[3] Drugs.com Vascepa Savings Card Info